Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Healy

Showing results (231-240 of 559) with videos related to

Pageof 56
Sort By:
Multiple Sclerosis and Related Disorders|August 3, 2019
Discontinuation of disease-modifying therapy for patients with relapsing-remitting multiple sclerosis: Effect on clinical and MRI outcomesHajime Yano, Cindy Gonzalez, Brian C Healy, et al.
Fitoterapia|August 5, 2017
5,6,7,3',4',5'-Hexamethoxyflavone from the Australian plant Eremophila debilis (Myoporaceae)Mark S Butler, Peter C Healy, Paul I Forster, et al.
The Journal of Organic Chemistry|March 11, 2006
Efficient formal synthesis of (+/-)-hyphodermin BLuke C Henderson, Wendy A Loughlin, Ian D Jenkins, et al.
Hip International : the Journal of Clinical and Experimental Research on Hip Pathology and Therapy|October 17, 2008
Medium-to-long term DEXA analysis of an uncemented (AML) femoral componentK K Stöhr, C Phillips, J C Healy, et al.
Bioorganic & Medicinal Chemistry|May 20, 2008
Evaluation of novel hyphodermin derivatives as glycogen phosphorylase a inhibitorsWendy A Loughlin, Gregory K Pierens, Maria J Petersson, et al.
The Journal of Organic Chemistry|March 28, 2008
Total synthesis of +/--hyphodermins A and DWendy A Loughlin, Ian D Jenkins, Luke C Henderson, et al.
Journal of the Neurological Sciences|January 6, 2009
Unbiased treatment effect estimates by modeling the disease process of multiple sclerosisBrian C Healy, Douglas L Hayden, Mehul P Sampat, et al.
Journal of Personality|June 12, 2013
When the going gets tough: the "why" of goal striving mattersNikos Ntoumanis, Laura C Healy, Constantine Sedikides, et al.
European Journal of Medicinal Chemistry|February 8, 2016
2-Oxo-1,2-dihydropyridinyl-3-yl amide-based GPa inhibitors: Design, synthesis and structure-activity relationship studyWendy A Loughlin, Ian D Jenkins, N David Karis, et al.
Clinical Radiology|July 12, 2001
Mycobacterial infections: still a millennium bug--the imaging features of mycobacterial infectionsD M Koh, J R Bell, G J Burkill, et al.
Pageof 56

Showing results (231-240 of 559) with videos related to

Sort By:
Pageof 56
Multiple Sclerosis and Related Disorders|August 3, 2019
Discontinuation of disease-modifying therapy for patients with relapsing-remitting multiple sclerosis: Effect on clinical and MRI outcomesHajime Yano, Cindy Gonzalez, Brian C Healy, et al.
Fitoterapia|August 5, 2017
5,6,7,3',4',5'-Hexamethoxyflavone from the Australian plant Eremophila debilis (Myoporaceae)Mark S Butler, Peter C Healy, Paul I Forster, et al.
The Journal of Organic Chemistry|March 11, 2006
Efficient formal synthesis of (+/-)-hyphodermin BLuke C Henderson, Wendy A Loughlin, Ian D Jenkins, et al.
Hip International : the Journal of Clinical and Experimental Research on Hip Pathology and Therapy|October 17, 2008
Medium-to-long term DEXA analysis of an uncemented (AML) femoral componentK K Stöhr, C Phillips, J C Healy, et al.
Bioorganic & Medicinal Chemistry|May 20, 2008
Evaluation of novel hyphodermin derivatives as glycogen phosphorylase a inhibitorsWendy A Loughlin, Gregory K Pierens, Maria J Petersson, et al.
The Journal of Organic Chemistry|March 28, 2008
Total synthesis of +/--hyphodermins A and DWendy A Loughlin, Ian D Jenkins, Luke C Henderson, et al.
Journal of the Neurological Sciences|January 6, 2009
Unbiased treatment effect estimates by modeling the disease process of multiple sclerosisBrian C Healy, Douglas L Hayden, Mehul P Sampat, et al.
Journal of Personality|June 12, 2013
When the going gets tough: the "why" of goal striving mattersNikos Ntoumanis, Laura C Healy, Constantine Sedikides, et al.
European Journal of Medicinal Chemistry|February 8, 2016
2-Oxo-1,2-dihydropyridinyl-3-yl amide-based GPa inhibitors: Design, synthesis and structure-activity relationship studyWendy A Loughlin, Ian D Jenkins, N David Karis, et al.
Clinical Radiology|July 12, 2001
Mycobacterial infections: still a millennium bug--the imaging features of mycobacterial infectionsD M Koh, J R Bell, G J Burkill, et al.
Pageof 56